How many FDA warning letters has Medtronic Navigation, Inc.-Boxborough received?

Argus HQ has not recorded an FDA warning letter for Medtronic Navigation, Inc.-Boxborough in our current dataset.

What FDA recalls has Medtronic Navigation, Inc.-Boxborough issued?

Argus HQ has recorded 1 FDA recall tied to Medtronic Navigation, Inc.-Boxborough.

Is Medtronic Navigation, Inc.-Boxborough FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Medtronic Navigation, Inc.-Boxborough. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Medtronic Navigation, Inc.-Boxborough

Name: FDA Enforcement Actions Against Medtronic Navigation, Inc.-Boxborough
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_recall · device_recall2026-06-24
Medtronic Navigation, Inc.-Boxborough — Class II recall: Medtronic O-arm O2 Imaging System. Model Number: BI70002000.

Frequently asked questions

How many FDA warning letters has Medtronic Navigation, Inc.-Boxborough received?: Argus HQ has not recorded an FDA warning letter for Medtronic Navigation, Inc.-Boxborough in our current dataset.
What FDA recalls has Medtronic Navigation, Inc.-Boxborough issued?: Argus HQ has recorded 1 FDA recall tied to Medtronic Navigation, Inc.-Boxborough.
Is Medtronic Navigation, Inc.-Boxborough FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Medtronic Navigation, Inc.-Boxborough. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.